FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117361424> ?p ?o ?g. }

• W2117361424 endingPage "681" @default.
• W2117361424 startingPage "679" @default.
• W2117361424 abstract "Biomarkers in MedicineVol. 7, No. 5 EditorialPteridine detection in urine: the future of cancer diagnostics?Yinfa Ma & Casey BurtonYinfa Ma* Author for correspondenceDepartment of Chemistry, Missouri University of Science & Technology, 400 West 11th Street, Rolla, MO 65409, USA and Center for Biomedical Science & Engineering, Missouri University of Science & Technology, Rolla, MO 65409, USA. Search for more papers by this authorEmail the corresponding author at yinfa@mst.edu & Casey BurtonDepartment of Chemistry, Missouri University of Science & Technology, 400 West 11th Street, Rolla, MO 65409, USA and Center for Biomedical Science & Engineering, Missouri University of Science & Technology, Rolla, MO 65409, USASearch for more papers by this authorPublished Online:17 Sep 2013https://doi.org/10.2217/bmm.13.88AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: cancer diagnosticsemerging cancer biomarkerspteridinesurinalysisReferences1 Noronha JM, Trehan S. Urinary excretion of total pteridines in cancer. In: Chemistry and Biology of Pteridines. Curtius H, Ghisla S, Blau N (Eds). Walter de Gruyter, Germany, 515–518 (1989).Google Scholar2 Gamagedara S, Gibbons SE, Ma Y. Investigation of urinary pteridines levels as potential biomarkers for noninvasive diagnosis of cancer. Clin. Chim. Acta412,120–128 (2011).Crossref, Medline, CAS, Google Scholar3 Kośliński P, Bujak R, Daghir E, Markuszewski MJ. Metabolic profiling of pteridines for determination of potential biomarkers in cancer diseases. Electrophoresis32,2044–2054 (2011).Crossref, Medline, CAS, Google Scholar4 Gibbons SE, Stayton I, Ma Y. Optimization of urinary pteridines analysis conditions by CE–LIF for clinical use in early cancer detection. Electrophoresis30,3591–3597 (2009).Crossref, Medline, CAS, Google Scholar5 de Lianos AM, Mansilla AE, Cañada-Cañada F, de la Peña AM. Separation and determination of 11 marker pteridines in human urine by liquid chromatography and fluorimetric detection. J. Sep. Sci.34,1283–1292 (2011).Crossref, Medline, Google Scholar6 Gamagedara S, Ma Y. Biomarker analysis for prostate cancer diagnosis using LC–MS and CE–MS. Bioanalysis3(18),2129–2142 (2011).Crossref, Medline, CAS, Google Scholar7 Han F, Huynh BH, Shi H, Lin B, Ma Y. Pteridine analysis in urine by capillary electrophoresis using laser-induced fluorescence detection. Anal. Chem.71,1265–1269 (1999).Crossref, Medline, CAS, Google Scholar8 Yuksel O, Sahin TT, Girgin G et al. Neopterin, catalase and superoxide dismutase in females with benign and malignant breast tumors. Pteridines18(4),132–138 (2007).Crossref, CAS, Google Scholar9 Trehan S, Noronha JM. Direct correlation between neopterin and excretion of total pteridines in normal controls and cancer subjects. J. Clin. Biochem. Nutr.19,107–113 (1995).Crossref, CAS, Google Scholar10 Allergi G, Costa Netto HJ, Ferreira Gomes LN, Costa de Oliveira ML, Scalco FB, de Aquino Neto FR. Determination of six pterins in urine by LC–MS/MS. Bioanalysis4(14),1739–1746 (2012).Crossref, Medline, Google Scholar11 Ogiwara S, Hidaka H, Sugimoto T, Teradaira R, Fujita K, Nagatsu T. Elevated levels of oncopterin, N2-(3-aminopropyl) biopterin, a new pterin compound, in urine from patients with solid and blood cancers. J. Biochem.113(1),1–3 (1993).Crossref, Medline, CAS, Google Scholar12 Tomandl J, Tallova J, Tomandlova M, Palyza V. Determination of total oncopterin, neopterin, and biopterin in human urine by high performance liquid chromatography with solid phase extraction. J. Sep. Sci.26,674–678 (2003).Crossref, CAS, Google Scholar101 Takashi S, Shoji O, Hiroyoshi H et al. EP-0608570 (1994).Google ScholarFiguresReferencesRelatedDetailsCited ByInsights into Molecular Structure of Pterins Suitable for Biomedical Applications3 December 2022 | International Journal of Molecular Sciences, Vol. 23, No. 23Establishing pteridine metabolism in a progressive isogenic breast cancer cell model – part II28 April 2022 | Metabolomics, Vol. 18, No. 5Establishing pteridine metabolism in a progressive isogenic breast cancer cell model17 December 2021 | Metabolomics, Vol. 18, No. 1Comparison of Pteridine Normalization Methods in Urine for Detection of Bladder Cancer20 August 2020 | Diagnostics, Vol. 10, No. 9Determination of Urinary Pterins by Capillary Electrophoresis Coupled with LED-Induced Fluorescence Detector24 March 2019 | Molecules, Vol. 24, No. 6Xanthine oxidase is hyper-active in Duchenne muscular dystrophyFree Radical Biology and Medicine, Vol. 129Pteridine determination in human serum with special emphasis on HPLC methods with fluorimetric detection12 June 2017 | Pteridines, Vol. 28, No. 2The role of urinary pteridines as disease biomarkers13 March 2017 | Pteridines, Vol. 28, No. 1Development of a high-performance liquid chromatography – Tandem mass spectrometry urinary pterinomics workflowAnalytica Chimica Acta, Vol. 927Daily variation and effect of dietary folate on urinary pteridines15 March 2016 | Metabolomics, Vol. 12, No. 5High-throughput intracellular pteridinic profiling by liquid chromatography–quadrupole time-of-flight mass spectrometryAnalytica Chimica Acta, Vol. 853HPLC determination of serum pteridine pattern as biomarkersTalanta, Vol. 128Normalization of urinary pteridines by urine specific gravity for early cancer detectionClinica Chimica Acta, Vol. 435Simultaneous Detection of Six Urinary Pteridines and Creatinine by High-Performance Liquid Chromatography-Tandem Mass Spectrometry for Clinical Breast Cancer Detection4 November 2013 | Analytical Chemistry, Vol. 85, No. 22 Vol. 7, No. 5 Follow us on social media for the latest updates Metrics Downloaded 64 times History Published online 17 September 2013 Published in print October 2013 Information© Future Medicine LtdKeywordscancer diagnosticsemerging cancer biomarkerspteridinesurinalysisFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download" @default.
• W2117361424 created "2016-06-24" @default.
• W2117361424 creator A5040035684 @default.
• W2117361424 creator A5081352482 @default.
• W2117361424 date "2013-10-01" @default.
• W2117361424 modified "2023-10-16" @default.
• W2117361424 title "Pteridine detection in urine: the future of cancer diagnostics?" @default.
• W2117361424 cites W1929224378 @default.
• W2117361424 cites W1965194127 @default.
• W2117361424 cites W2004716291 @default.
• W2117361424 cites W2015086264 @default.
• W2117361424 cites W2027593341 @default.
• W2117361424 cites W2035434261 @default.
• W2117361424 cites W2043129415 @default.
• W2117361424 cites W2053891227 @default.
• W2117361424 cites W2062783628 @default.
• W2117361424 cites W2113292061 @default.
• W2117361424 cites W2132812973 @default.
• W2117361424 cites W3128818114 @default.
• W2117361424 doi "https://doi.org/10.2217/bmm.13.88" @default.
• W2117361424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24044558" @default.
• W2117361424 hasPublicationYear "2013" @default.
• W2117361424 type Work @default.
• W2117361424 sameAs 2117361424 @default.
• W2117361424 citedByCount "15" @default.
• W2117361424 countsByYear W21173614242013 @default.
• W2117361424 countsByYear W21173614242014 @default.
• W2117361424 countsByYear W21173614242015 @default.
• W2117361424 countsByYear W21173614242016 @default.
• W2117361424 countsByYear W21173614242017 @default.
• W2117361424 countsByYear W21173614242018 @default.
• W2117361424 countsByYear W21173614242019 @default.
• W2117361424 countsByYear W21173614242020 @default.
• W2117361424 countsByYear W21173614242021 @default.
• W2117361424 countsByYear W21173614242022 @default.
• W2117361424 countsByYear W21173614242023 @default.
• W2117361424 crossrefType "journal-article" @default.
• W2117361424 hasAuthorship W2117361424A5040035684 @default.
• W2117361424 hasAuthorship W2117361424A5081352482 @default.
• W2117361424 hasConcept C161191863 @default.
• W2117361424 hasConcept C185592680 @default.
• W2117361424 hasConcept C2779473830 @default.
• W2117361424 hasConcept C3018419874 @default.
• W2117361424 hasConcept C41008148 @default.
• W2117361424 hasConcept C509550671 @default.
• W2117361424 hasConcept C55493867 @default.
• W2117361424 hasConcept C71924100 @default.
• W2117361424 hasConceptScore W2117361424C161191863 @default.
• W2117361424 hasConceptScore W2117361424C185592680 @default.
• W2117361424 hasConceptScore W2117361424C2779473830 @default.
• W2117361424 hasConceptScore W2117361424C3018419874 @default.
• W2117361424 hasConceptScore W2117361424C41008148 @default.
• W2117361424 hasConceptScore W2117361424C509550671 @default.
• W2117361424 hasConceptScore W2117361424C55493867 @default.
• W2117361424 hasConceptScore W2117361424C71924100 @default.
• W2117361424 hasIssue "5" @default.
• W2117361424 hasLocation W21173614241 @default.
• W2117361424 hasLocation W21173614242 @default.
• W2117361424 hasOpenAccess W2117361424 @default.
• W2117361424 hasPrimaryLocation W21173614241 @default.
• W2117361424 hasRelatedWork W1546820302 @default.
• W2117361424 hasRelatedWork W1591751831 @default.
• W2117361424 hasRelatedWork W2092144790 @default.
• W2117361424 hasRelatedWork W2105178385 @default.
• W2117361424 hasRelatedWork W2259200907 @default.
• W2117361424 hasRelatedWork W2286894082 @default.
• W2117361424 hasRelatedWork W2297905513 @default.
• W2117361424 hasRelatedWork W2594889638 @default.
• W2117361424 hasRelatedWork W2626354961 @default.
• W2117361424 hasRelatedWork W2902997999 @default.
• W2117361424 hasVolume "7" @default.
• W2117361424 isParatext "false" @default.
• W2117361424 isRetracted "false" @default.
• W2117361424 magId "2117361424" @default.
• W2117361424 workType "article" @default.